BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 32160045)

  • 1. THERAPEUTIC EFFECTS OF COMBINATION REGIMENS INCLUDING METHIMAZOLE ON GRAVES HYPERTHYROIDISM: A NETWORK META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS.
    Wang M; Yu Y
    Endocr Pract; 2020 Jun; 26(6):675-687. PubMed ID: 32160045
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical manifestations and early effectiveness of methimazole in patients with graves' hyperthyroidism-related severe hepatic dysfunction.
    Li C; Wang KL; Hu JH; Su HB
    Scand J Gastroenterol; 2023; 58(12):1514-1522. PubMed ID: 37545358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of selenium on short-term control of hyperthyroidism due to Graves' disease treated with methimazole: results of a randomized clinical trial.
    Leo M; Bartalena L; Rotondo Dottore G; Piantanida E; Premoli P; Ionni I; Di Cera M; Masiello E; Sassi L; Tanda ML; Latrofa F; Vitti P; Marcocci C; Marinò M
    J Endocrinol Invest; 2017 Mar; 40(3):281-287. PubMed ID: 27734319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of methimazole and propylthiouracil in patients with hyperthyroidism caused by Graves' disease.
    Nakamura H; Noh JY; Itoh K; Fukata S; Miyauchi A; Hamada N
    J Clin Endocrinol Metab; 2007 Jun; 92(6):2157-62. PubMed ID: 17389704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of single daily dose of methimazole and propylthiouracil in the treatment of Graves' hyperthyroidism.
    He CT; Hsieh AT; Pei D; Hung YJ; Wu LY; Yang TC; Lian WC; Huang WS; Kuo SW
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):676-81. PubMed ID: 15163329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficiency and safety of methimazole and propylthiouracil in hyperthyroidism: A meta-analysis of randomized controlled trials.
    Tan S; Chen L; Jin L; Fu X
    Medicine (Baltimore); 2021 Jul; 100(30):e26707. PubMed ID: 34397700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of efficacy and adverse effects between methimazole 15 mg+inorganic iodine 38 mg/day and methimazole 30 mg/day as initial therapy for Graves' disease patients with moderate to severe hyperthyroidism.
    Sato S; Noh JY; Sato S; Suzuki M; Yasuda S; Matsumoto M; Kunii Y; Mukasa K; Sugino K; Ito K; Nagataki S; Taniyama M
    Thyroid; 2015 Jan; 25(1):43-50. PubMed ID: 25178068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment with lithium prevents serum thyroid hormone increase after thionamide withdrawal and radioiodine therapy in patients with Graves' disease.
    Bogazzi F; Bartalena L; Campomori A; Brogioni S; Traino C; De Martino F; Rossi G; Lippi F; Pinchera A; Martino E
    J Clin Endocrinol Metab; 2002 Oct; 87(10):4490-5. PubMed ID: 12364424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum free triiodothyronine to free thyroxine ratio enables early prediction of the outcome of antithyroid drug therapy in patients with Graves' hyperthyroidism.
    Tajiri J; Noguchi S; Morita M; Tamaru M; Murakami N; Kato R
    Endocrinol Jpn; 1991 Dec; 38(6):683-7. PubMed ID: 1726635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benefit of short-term iodide supplementation to antithyroid drug treatment of thyrotoxicosis due to Graves' disease.
    Takata K; Amino N; Kubota S; Sasaki I; Nishihara E; Kudo T; Ito M; Fukata S; Miyauchi A
    Clin Endocrinol (Oxf); 2010 Jun; 72(6):845-50. PubMed ID: 19912243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of 1 alpha-hydroxyvitamin D3 on serum levels of thyroid hormones in hyperthyroid patients with untreated Graves' disease.
    Kawakami-Tani T; Fukawa E; Tanaka H; Abe Y; Makino I
    Metabolism; 1997 Oct; 46(10):1184-8. PubMed ID: 9322804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose-Dependent Influence of Antithyroid Drugs on the Difference in Free Thyroxine Levels between Mothers with Graves' Hyperthyroidism and Their Neonates.
    Iwaki H; Ohba K; Okada E; Murakoshi T; Kashiwabara Y; Hayashi C; Matsushita A; Sasaki S; Suda T; Oki Y; Gemma R
    Eur Thyroid J; 2021 Jul; 10(5):372-381. PubMed ID: 34540707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early changes of thyroid hormone concentrations after (131)I therapy in Graves' patients pretreated or not with methimazole.
    Pirnat E; Zaletel K; Gaberscek S; Fidler V; Hojker S
    Nuklearmedizin; 2004 Aug; 43(4):129-34. PubMed ID: 15316580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pilot study on the beneficial effects of additional selenium supplementation to methimazole for treating patients with Graves’ disease.
    Xu B; Wu D; Ying H; Zhang Y
    Turk J Med Sci; 2019 Jun; 49(3):715-722. PubMed ID: 31023005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myopathy after rapid correction of hyperthyroidism: A case report and review of literature.
    Lu R; Wang H; Hong T; Gao H
    Medicine (Baltimore); 2020 Jan; 99(3):e18878. PubMed ID: 32011514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triiodothyronine and thyroxine in hyperthyroidism. Comparison of the acute changes during therapy with antithyroid agents.
    Abuid J; Larsen PR
    J Clin Invest; 1974 Jul; 54(1):201-8. PubMed ID: 4134836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of hyperthyroidism with hypercalcemia in Xindu district and the efficacy of vitamin D3 treatment in these patients: a randomized trial.
    Mei X; Zeng J; Dai WX; Yang HL; Li Y; Tang MW; Qiu P
    Ann Palliat Med; 2021 Sep; 10(9):9640-9649. PubMed ID: 34628889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of combination therapy with propylthiouracil and cholestyramine in the treatment of Graves' hyperthyroidism.
    Tsai WC; Pei D; Wang TF; Wu DA; Li JC; Wei CL; Lee CH; Chen SP; Kuo SW
    Clin Endocrinol (Oxf); 2005 May; 62(5):521-4. PubMed ID: 15853819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Free triiodothyronine to free thyroxine ratio in the differential diagnosis of thyrotoxicosis and hyperthyroidism: A retrospective study.
    Tura Bahadır Ç; Yılmaz M; Kılıçkan E
    Int J Clin Pract; 2021 May; 75(5):e14003. PubMed ID: 33403716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benefits of Long-Term Continuation of Low-Dose Methimazole Therapy in the Prevention of Recurrent Hyperthyroidism in Graves' Hyperthyroid Patients: A Randomized Prospective Controlled Study.
    Lertwattanarak R; Kunavisarut T; Sriussadaporn S
    Int J Endocrinol; 2022; 2022():1705740. PubMed ID: 36267362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.